Table 3 Results of SPARC genotyping analysis in AML samples.
| Â | Â | AML patients | Healthy donors | OR (95% CI) |
|---|---|---|---|---|
SNP 1474 | GG | 13 | 20 | Â |
| Â | GA | 0 | 0 | Â |
| Â | AA | 0 | 0 | Â |
| Â | Allelic Frequency A (%) | Â | Â | Â |
SNP 1551 | GG | 2 | 7 | Â |
| Â | GC | 8 | 7 | Â |
| Â | CC | 3 | 6 | Â |
|  | Allelic Frequency C (%) | 53 | 47 | 2.9 (0.5–17.3) |
SNP 1922 | TT | 13 | 5 | Â |
| Â | TG | 2 | 1 | Â |
| Â | GG | 0 | 0 | Â |
|  | Allelic Frequency G (%) | 13 |  | 0.8 (0.05–10.5) |
SNP 2072 | CC | 4 | 10 | Â |
| Â | CT | 7 | 3 | Â |
| Â | TT | 4 | 4 | Â |
|  | Allelic Frequency T (%) | 50 | 32 | 3.9 (0.9–17.5) |
SNP 2168 | GG | 3 | 11 | Â |
| Â | GA | 6 | 1 | Â |
| Â | AA | 4 | 5 | Â |
|  | Allelic Frequency A (%) | 54 | 32 | 6.1 (1.2–31.2) |